How has been the historical performance of Zydus Lifesci.?

Answer:The historical performance of Zydus Lifesci shows a consistent growth trend in net sales and profits over the years, with significant increases noted in the latest fiscal year.

Breakdown:
Zydus Lifesci's net sales have risen from 13,165.60 Cr in March 2019 to 23,241.50 Cr in March 2025, demonstrating a robust growth trajectory. The total operating income followed a similar upward trend, reaching 23,241.50 Cr in March 2025, up from 19,547.40 Cr in March 2024. The company's operating profit (PBDIT) also increased significantly, from 3,184.60 Cr in March 2019 to 7,328.00 Cr in March 2025, indicating improved operational efficiency. Profit before tax saw a notable rise to 6,026.70 Cr in March 2025 from 4,808.90 Cr in March 2024, while profit after tax reached 4,614.80 Cr, up from 3,831.40 Cr in the previous year. The earnings per share (EPS) reflected this positive trend, increasing to 44.99 in March 2025 from 38.36 in March 2024. On the balance sheet, total assets grew to 34,857.90 Cr in March 2025 from 27,636.60 Cr in March 2024, while total liabilities also increased, indicating a proportional growth in the company's financial structure. Cash flow from operating activities improved significantly to 6,776.00 Cr in March 2025, compared to 3,196.00 Cr in March 2024, showcasing enhanced cash generation capabilities. Overall, Zydus Lifesci's financial performance reflects a strong upward trend across key metrics over the years.